# nference and Cedars-Sinai Build AI Platform Drawing on Records of Over 5 Million Patients

> nference and Cedars-Sinai will build a secure platform analyzing de-identified clinical data from more than 5 million patients to speed biomedical research.

- Published: 2026-11-20T11:16:11+00:00
- Section: Partnerships
- Author: News Desk
- URL: https://newsforagent.com/news/2026-11-20/nference-cedars-sinai-ai-platform-partnership
- Source: [PR Newswire](https://www.prnewswire.com/news-releases/nference-enters-long-term-partnership-with-cedars-sinai-to-develop-ai-enabled-platform-for-advancing-clinical-research-and-patient-care-302946419.html)

## Key takeaways

- nference announced a long-term strategic collaboration with Cedars-Sinai to build a secure platform for de-identified, multimodal clinical data.
- The platform draws on more than a decade of longitudinal records from over 5 million patients.
- The platform is intended to support investigator-led studies, grant-funded research, education and quality improvement.

Nference announced a long-term strategic collaboration with Cedars-Sinai to build a secure platform for analyzing de-identified, multimodal clinical data from more than 5 million patients, according to a [PR Newswire](https://www.prnewswire.com/news-releases/nference-enters-long-term-partnership-with-cedars-sinai-to-develop-ai-enabled-platform-for-advancing-clinical-research-and-patient-care-302946419.html) announcement on November 20, 2026. The company said the platform aims to accelerate biomedical discovery and support investigator-led studies.

## How the nference Platform Handles Patient Data

Nference will architect the platform using its federated software, which protects patient privacy, harmonizes multimodal data and supports longitudinal curation with physician-adjudication. The platform will synthesize insights from de-identified clinical notes, laboratory results, medications, diagnostic reports, radiology and pathology imaging, genomic information, patient-consented biospecimen, electrophysiology waveforms, vitals and flowsheets.

The data sets represent decades of patient care, with more than a decade of longitudinal records from over 5 million patients and frequent refreshes as routine care progresses. The platform is intended to support investigator-led studies, grant-funded research, education, quality improvement and collaboration with life science industry partners, and to give Cedars-Sinai researchers a foundation to develop and evaluate new AI models.

"Understanding health and disease requires connecting what is happening across organs, across clinical modalities, and across decades of each patient's medical journey," said Venky Soundararajan, Ph.D., founder and co-CEO of nference. "We are building a distinctive foundation for whole-body spatial intelligence to enable triangulation across disparate and unstructured modalities, so that even the most ambitious scientific questions may become more rapidly tractable and result in creative solutions for serving patients worldwide."

Sumeet Chugh, MD, vice dean and chief artificial intelligence health research officer at [Cedars-Sinai](https://akta.pro/company-profiles/0000fe8/cedars-sinai), said: "We expect this collaboration with nference will provide our clinicians and scientists with new ways to learn from the collective experience of patient care, help validate scientific hypotheses and accelerate biomedical discovery."

Cedars-Sinai's Prometheus Biosciences, spun off from its inflammatory bowel disease research, was acquired by Merck for $10.8 billion in 2023, with the system receiving about $899 million, Becker's Hospital Review reported on October 23, 2026.

## nference's Earlier Health System Deals

Nference and Novo Nordisk announced a strategic collaboration in November 2026 to advance research in cardiometabolic disease, combining Novo's clinical trial data with nference's AI technology and federated healthcare data network, Yahoo reported.

In September 2026, Rush University System for Health and nference announced a long-term partnership to build a Rush-hosted clinical analytics platform for de-identified multimodal data covering nearly 5 million patients, Aijourn reported.

Nference lists long-term strategic partnerships with academic medical centers and integrated delivery networks including Mayo Clinic, Duke Health, Vanderbilt University Medical Center, Emory Healthcare, Banner Health, Mercy Health and Rush University System for Health, according to its [company website](https://nference.com).

## Companies in this story

- nference · website: https://nference.com
- [Cedars Sinai company profile](https://akta.pro/company-profiles/0000fe8/cedars-sinai) · website: https://www.cedars-sinai.org

---
News for Agent · https://newsforagent.com/llms.txt
